Gambaran Umum
Embecta Corp., based in the United States, operates primarily in the medical devices sector, specializing in diabetes care technology. The company, established as an independent entity following its spin-off from Becton, Dickinson and Company in 2022, focuses on the development, manufacture, and sale of innovative products and solutions for diabetes management. Key products include insulin delivery devices, which are pivotal in their offering, addressing a growing market need amidst rising global diabetes prevalence. Embecta's projects and research initiatives aim to enhance the efficacy and convenience of diabetes care, thereby improving patient outcomes and adherence to management protocols. The firm leverages advanced technology to stay at the forefront of the diabetes care industry, continuously seeking to improve and expand its product portfolio.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Embecta Corp. per 2025 Jun 30 adalah 1,102.50 MM.
- Nilai operating income untuk Embecta Corp. per 2025 Jun 30 adalah 73.80 MM.
- Nilai net income untuk Embecta Corp. per 2025 Jun 30 adalah 83.60 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,102.50 | 73.80 | 83.60 |
2025-03-31 | 1,079.50 | 47.00 | 52.80 |
2024-12-31 | 1,107.70 | 41.30 | 58.20 |
2024-09-30 | 1,123.10 | 48.60 | 78.30 |
2024-06-30 | 1,118.90 | 90.40 | 69.70 |
2024-03-31 | 1,132.50 | 92.40 | 70.20 |
2023-12-31 | 1,122.40 | 100.80 | 55.30 |
2023-09-30 | 1,120.80 | 125.70 | 70.40 |
2023-06-30 | 1,113.50 | 292.20 | 47.20 |
2023-03-31 | 1,118.50 | 317.10 | 94.40 |
2022-12-31 | 1,115.90 | 342.20 | 160.00 |
2022-09-30 | 1,129.50 | 368.50 | 223.60 |
2022-06-30 | 1,155.70 | 451.20 | 337.70 |
2022-03-31 | 1,159.60 | 462.80 | 380.00 |
2021-12-31 | 1,169.30 | 482.90 | 408.30 |
2021-09-30 | 1,165.30 | 492.00 | 414.80 |
2020-09-30 | 1,085.50 | 486.50 | 427.60 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 1.01 | 0.99 |
2024-09-30 | 1.36 | 1.34 |
2024-06-30 | 1.21 | 1.20 |
2024-03-31 | 1.22 | 1.22 |
2023-12-31 | 0.96 | 0.96 |
2023-09-30 | 1.23 | 1.22 |
2023-06-30 | 0.83 | 0.83 |
2023-03-31 | 1.66 | 1.64 |
2022-12-31 | 2.80 | 2.78 |
2022-09-30 | 3.92 | 3.89 |
2022-06-30 | 5.92 | 5.90 |
2022-03-31 | 6.67 | 6.67 |
2021-12-31 | ||
2021-09-30 | 7.28 | 7.28 |
2020-09-30 | 7.50 | 7.50 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Embecta Corp. per 2025 Jun 30 adalah 134.30 MM.
- Nilai cash from investing activities untuk Embecta Corp. per 2025 Jun 30 adalah -2.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Embecta Corp. per 2025 Jun 30 adalah -181.70 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 134.30 | -2.00 | -181.70 |
2025-03-31 | 51.00 | -11.30 | -130.60 |
2024-12-31 | 43.50 | -14.60 | -105.10 |
2024-09-30 | 35.70 | -15.80 | -73.40 |
2024-06-30 | 38.70 | -25.00 | -46.50 |
2024-03-31 | 31.50 | -22.10 | -47.20 |
2023-12-31 | -5.80 | -24.50 | -56.10 |
2023-09-30 | 67.70 | -26.50 | -48.70 |
2023-06-30 | 96.10 | -25.90 | -46.10 |
2023-03-31 | 138.20 | -24.40 | -30.60 |
2022-12-31 | 333.80 | -24.40 | 80.40 |
2022-09-30 | 412.20 | -24.00 | -48.00 |
2022-06-30 | 439.70 | -28.70 | -113.10 |
2022-03-31 | 536.60 | -31.10 | -238.40 |
2021-12-31 | 473.70 | -31.60 | -442.10 |
2021-09-30 | 456.30 | -39.20 | -417.10 |
2020-09-30 | 498.50 | -41.90 | -456.60 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk Embecta Corp. pada 2025 Jun 30 adalah 0.57.
- roe untuk Embecta Corp. pada 2025 Jun 30 adalah 0.74.
- roic untuk Embecta Corp. pada 2025 Jun 30 adalah 0.74.
- croic untuk Embecta Corp. pada 2025 Jun 30 adalah 0.00.
- ocroic untuk Embecta Corp. pada 2025 Jun 30 adalah 0.86.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2025-03-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2024-12-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2024-09-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2024-06-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2024-03-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2023-12-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2023-09-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2023-06-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2023-03-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2022-12-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2022-09-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2022-06-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2022-03-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2021-12-31 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2021-09-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
2020-09-30 | 0.57 | 0.74 | 0.74 | 0.00 | 0.86 |
Gross Margins
- marjin kotor untuk Embecta Corp. pada 2025 Jun 30 adalah 0.70.
- marjin bersih untuk Embecta Corp. pada 2025 Jun 30 adalah 0.39.
- marjin operasi untuk Embecta Corp. pada 2025 Jun 30 adalah 0.45.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.70 | 0.39 | 0.45 |
2025-03-31 | 0.70 | 0.39 | 0.45 |
2024-12-31 | 0.70 | 0.39 | 0.45 |
2024-09-30 | 0.70 | 0.39 | 0.45 |
2024-06-30 | 0.70 | 0.39 | 0.45 |
2024-03-31 | 0.70 | 0.39 | 0.45 |
2023-12-31 | 0.70 | 0.39 | 0.45 |
2023-09-30 | 0.70 | 0.39 | 0.45 |
2023-06-30 | 0.70 | 0.39 | 0.45 |
2023-03-31 | 0.70 | 0.39 | 0.45 |
2022-12-31 | 0.70 | 0.39 | 0.45 |
2022-09-30 | 0.70 | 0.39 | 0.45 |
2022-06-30 | 0.70 | 0.39 | 0.45 |
2022-03-31 | 0.70 | 0.39 | 0.45 |
2021-12-31 | 0.70 | 0.39 | 0.45 |
2021-09-30 | 0.70 | 0.39 | 0.45 |
2020-09-30 | 0.70 | 0.39 | 0.45 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1872789 |
Grupong Pang-industriya
SIC 3841 - Surgical and Medical Instruments and Apparatus |